| 000 | 01819 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515230532.0 | ||
| 264 | 0 | _c20110203 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1559-7016 | ||
| 024 | 7 |
_a10.1038/jcbfm.2010.91 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSlifstein, Mark | |
| 245 | 0 | 0 |
_aCharacterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride. _h[electronic resource] |
| 260 |
_bJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism _cJan 2011 |
||
| 300 |
_a293-304 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBenzazepines |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCerebral Cortex _xdiagnostic imaging |
| 650 | 0 | 4 |
_aDopamine Agonists _xblood |
| 650 | 0 | 4 | _aDopamine Antagonists |
| 650 | 0 | 4 | _aImage Processing, Computer-Assisted |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPapio anubis |
| 650 | 0 | 4 |
_aPhenanthridines _xpharmacokinetics |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aRaclopride |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 |
_aReceptors, Dopamine D1 _xagonists |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xmetabolism |
| 700 | 1 | _aSuckow, Raymond F | |
| 700 | 1 | _aJavitch, Jonathan A | |
| 700 | 1 | _aCooper, Thomas | |
| 700 | 1 | _aLieberman, Jeffrey | |
| 700 | 1 | _aAbi-Dargham, Anissa | |
| 773 | 0 |
_tJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism _gvol. 31 _gno. 1 _gp. 293-304 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/jcbfm.2010.91 _zAvailable from publisher's website |
| 999 |
_c19919922 _d19919922 |
||